Schedule 13G ownership disclosure

Calithera Biosciences, Inc.

Security class unavailable · CUSIP: 13089P101

Event date: 2021-01-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,000,000
Percent of class
5.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000504
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Jan 25, 2021
Reporting period
Jan 13, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub